Brian R. Edlin, MD

Articles by Brian R. Edlin, MD

Value of Expanding HCV Screening and Treatment Policies in the United States

ByMark T. Linthicum, MPP,Yuri Sanchez Gonzalez, PhD,Karen Mulligan, PhD,Gigi A. Moreno, PhD,David Dreyfus, DBA,Timothy Juday, PhD,Steven E. Marx, PharmD,Darius N. Lakdawalla, PhD,Brian R. Edlin, MD,Ron Brookmeyer, PhD

May 3rd 2016

Expanding screening for hepatitis C virus infection may generate substantial benefits for patients and society, but only when paired with expanded treatment policies.

Latest Updated Articles

Value of Expanding HCV Screening and Treatment Policies in the United States
May 3rd 2016

Brian R. Edlin, MD

Articles by Brian R. Edlin, MD

Value of Expanding HCV Screening and Treatment Policies in the United States

Latest Updated Articles

Trending on AJMC

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19

Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy

AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD

Diet, Exercise, and Mental Health May Help Complement Psoriasis Treatment